The popular weight loss drugs Ozempic, Wegovy, and Mounjaro are facing scrutiny over severe side effects not adequately disclosed to patients. Based on a compound found in Gila monster venom, these GLP-1 drugs induce weight loss but are now the subject of over 4,400 lawsuits. Patients are reporting devastating health issues including gastroparesis (stomach paralysis), bowel obstruction, organ failure, sudden vision loss, and death. Nutrition expert Kim Bright explains that the drugs cause a disproportionate loss of lean muscle mass over fat, leading to an increase in body fat percentage
